Skip to main content
Premium Trial:

Request an Annual Quote

And We Thought the Difference Was Just Taste in Footwear

Over at his BBGM blog, Deepak Singh mulls over the differences between academia and industry. Using his software experience as a foundation, Singh writes that from what he's seen, the major difference comes in process control: While "basic research and early stage discovery can be a lot like academia," he blogs, "research gets a lot more 'locked down' so to speak" in the drug development phase. He notes that software in a clinical setting tends to have far fewer features because it's tough to allow for that kind of complexity in a very controlled, highly regulated environment.


The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.